Intense Exercise May Extend Life for Advanced PCa Patients
 
				
				    Metastatic castration-resistant prostate cancer (mCRPC) is a scary diagnosis. Castration-resistant means  that hormone therapy) depriving the body of male hormones) can no longer halt the cancer’s inevitable  spread. Thankfully, advances in immunotherapies and other drugs do extend life, and survival for  hormone-resistant patients now averages 32 months. However...				     keep reading 
				
			 
						 
				 
				 
				 
				